| Year |
Citation |
Score |
| 2010 |
Gaydess A, Duysen E, Li Y, Gilman V, Kabanov A, Lockridge O, Bronich T. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. Chemico-Biological Interactions. 187: 295-8. PMID 20060815 DOI: 10.1016/J.Cbi.2010.01.005 |
0.403 |
|
| 2008 |
Duysen EG, Li B, Carlson M, Li YF, Wieseler S, Hinrichs SH, Lockridge O. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice. Basic & Clinical Pharmacology & Toxicology. 103: 514-21. PMID 19067679 DOI: 10.1111/J.1742-7843.2008.00259.X |
0.382 |
|
| 2008 |
Ding SJ, Carr J, Carlson JE, Tong L, Xue W, Li Y, Schopfer LM, Li B, Nachon F, Asojo O, Thompson CM, Hinrichs SH, Masson P, Lockridge O. Five tyrosines and two serines in human albumin are labeled by the organophosphorus agent FP-biotin Chemical Research in Toxicology. 21: 1787-1794. PMID 18707141 DOI: 10.1021/Tx800144Z |
0.435 |
|
| 2007 |
Li Y, Li X, Li H, Lockridge O, Wang G. A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation. Protein Expression and Purification. 54: 157-65. PMID 17382559 DOI: 10.1016/j.pep.2007.02.003 |
0.454 |
|
| 2006 |
Li X, Li Y, Peterkofsky A, Wang G. NMR studies of aurein 1.2 analogs. Biochimica Et Biophysica Acta. 1758: 1203-14. PMID 16716252 DOI: 10.1016/J.Bbamem.2006.03.032 |
0.313 |
|
| 2006 |
Li X, Li Y, Han H, Miller DW, Wang G. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. Journal of the American Chemical Society. 128: 5776-85. PMID 16637646 DOI: 10.1021/Ja0584875 |
0.317 |
|
| 2006 |
Li Y, Li X, Wang G. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expression and Purification. 47: 498-505. PMID 16325420 DOI: 10.1016/J.Pep.2005.10.022 |
0.327 |
|
| Show low-probability matches. |